MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-22-0051699
Serine Pharma Private Limited
Serine Pharma Private Limited - pharma in Mysore, Karnataka, India. Directors, charges & compliance details.
Revenue · FY 2025
₹95,953
Latest filing
Net loss · FY 2025
₹2.11 Lakh
Net margin -220.1%
EBITDA · FY 2025
-₹2.08 Lakh
EBITDA margin -216.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5.5 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
3
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Serine Pharma Private Limited
Data last updated:
Serine Pharma Private Limited is a private limited company based in Mysore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 April 2022.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24304KA2022PTC160444.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5.5 Lakh. It is led by directors including Nazima Begum Laskar (Managing Director) and Fulowar Ahmed.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.3836 Bh 16/1A 3rd Main Road Thilaknagara, Mysore, Karnataka, India – 570001.
As per the financials filed for FY 2025, the company reported a revenue of ₹95,953. For the same year it recorded a net loss of ₹2.11 Lakh (net margin -220.1%) and EBITDA of -₹2.08 Lakh (EBITDA margin -216.8%).
Serine Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-22-0051699).
Company details
CIN U24304KA2022PTC160444
Registration Number 160444
Incorporation Date 25 April 2022
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-KR-22-0051699
Recognitions & Rankings of Serine Pharma
Contact details
Serine Pharma Private Limited's registered office is in Mysore, Karnataka.
- Registered AddressNo.3836 Bh 16/1A 3rd Main Road Thilaknagara, Mysore, Karnataka, India – 570001
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Serine Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Serine Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Serine Pharma Private Limited, buy the company report.
Financials of Serine Pharma Private Limited
FY 2025 filings availableSerine Pharma Private Limited reported revenue of ₹95,953 for FY 2025.
Revenue · FY 2025
₹95,953
Net loss · FY 2025
₹2.11 Lakh margin -220.1%
EBITDA · FY 2025
-₹2.08 Lakh margin -216.8%
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹2.08 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹2.11 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -216.8% | ||
| Net Profit Margin | -220.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Serine Pharma Private Limited, buy the company report.
Board of directors of Serine Pharma Private Limited
Serine Pharma has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Fulowar Ahmed | Director | 25 Apr 2022 | 4 Years 6 Months | Current |
| Shahidul Islam | Director | 25 Apr 2022 | 4 Years 6 Months | Current |
| Nazima Begum Laskar | Managing Director | 25 Apr 2022 | 4 Years 6 Months | Current |
Peer comparison
Serine Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Maxazan Healthcare Private Limited | ₹99,221 (FY 2025) | 133.0% | Lucknow, Uttar Pradesh, India | |||
| Aglenova Pharmaceutical Private Limited | ₹98,877 (FY 2025) | New Delhi, Delhi, India | ||||
| Skyvin Healthcare Private Limited | ₹98,836 (FY 2025) | -86.0% | Mumbai, Maharashtra, India | |||
| Getson Pharmaceuticals Private Limited | ₹98,510 (FY 2025) | 44.0% | Delhi, India | |||
| Roykar Pharmaceuticals Private Limited | ₹97,800 (FY 2025) | -71.0% | Pune, Maharashtra, India | |||
| Serine Pharma Private Limitedthis company | ₹95,953 (FY 2025) | -₹2.11 Lakh | -220.1% | Mysore, Karnataka, India | ||
| Hira Filters Private Limited | ₹95,620 (FY 2025) | -45.0% | Nalagarh, Himachal Pradesh, India | |||
| Appl Pharmalab Private Limited | ₹90,500 (FY 2025) | -95.0% | Jaipur, Rajasthan, India | |||
| Lifecore Pharmaceuticals Private Limited | ₹85,010 (FY 2025) | Puducherry, India | ||||
| Neopolysyn Chemical (India) Private Limited | ₹82,500 (FY 2025) | -73.0% | Thane, Maharashtra, India | |||
| Polykevpharma Private Limited | ₹81,760 (FY 2025) | -80.0% | Beed, Maharashtra, India |
To see the full peer comparison of Serine Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Serine Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Serine Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Serine Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Serine Pharma Private Limited has 3 board changes on record since 2022: 3 appointments. The latest: Fulowar Ahmed was appointed as Director on 25 Apr 2022.
AGM
Serine Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Serine Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Appointed
Fulowar Ahmed was appointed as Director.
Appointed
Nazima Begum Laskar was appointed as Managing Director.
Appointed
Shahidul Islam was appointed as Director.
Incorporation
25 Apr 2022
Serine Pharma Private Limited was registered on 25 Apr 2022 with Roc Bangalore & aged 4 years 6 months as per MCA records.
Frequently asked questions
Serine Pharma is an active private limited company based in Mysore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 April 2022 (4+ years old) and is registered under CIN U24304KA2022PTC160444.
Serine Pharma has 3 current directors:
- Nazima Begum Laskar - Managing Director
- Fulowar Ahmed - Director
- Shahidul Islam - Director
The latest financial statements of Serine Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Serine Pharma is U24304KA2022PTC160444. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Serine Pharma was incorporated on 25 April 2022, making it 4+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Serine Pharma by revenue are Maxazan Healthcare Private Limited, Aglenova Pharmaceutical Private Limited, Skyvin Healthcare Private Limited, Getson Pharmaceuticals Private Limited, Roykar Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Fulowar Ahmed was appointed as Director on 25 Apr 2022. Nazima Begum Laskar was appointed as Managing Director on 25 Apr 2022. Shahidul Islam was appointed as Director on 25 Apr 2022.
Yes, Serine Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-22-0051699).
The registered office of Serine Pharma is at No.3836 Bh 161A 3rd Main Road Thilaknagara, Mysore, Karnataka, India – 570001.
Serine Pharma operates in the pharma industry, in the drug formulation and development segment.
Serine Pharma can be reached at its registered office: No.3836 Bh 161A 3rd Main Road Thilaknagara, Mysore, Karnataka, India – 570001.